Coral Laboratories Ltd
Ticker: CORALAB
Decent
54/100
☆ Add to Watchlist
Investing Reference
Price
511.00
Market Cap
182.56
Debt/Equity
0.0177
ROE %
12.760
PB
0.9074
Promoter %
71.511
Pledge %
0.000
1Y Rev Growth %
37.468
5Y Rev Growth %
10.172
NP Margin %
19.465
NP Margin 5Y Avg %
13.826
Trading Reference
1M Return %
0.841
6M Return %
-21.433
1Y Return %
-44.628
% Away 52W High
88.063
% Away 52W Low
15.467
Daily Volume
569
Investment Verdict
Buy
Score 92/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 22/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Coral Laboratories Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock can break through the resistance level at $15, there is a potential upside of 20%. However, if it falls below the support level of $12, there could be a downside risk of 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
U
Upsurge Investment and Finance Ltd
Upsurge Investment and Finance Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
N
Naturite Agro Products Ltd
Naturite Agro Products Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
U
Umang Dairies Ltd
Umang Dairies Ltd presents a risky investment due to inconsistent growth and market challenges, despite operating in a necessary sector.
View details
A
Aeron Composite Ltd
Aeron Composite Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
P
Panchsheel Organics Ltd
Panchsheel Organics Ltd presents a mixed outlook with significant risks, particularly in execution and market sentiment.
View details
H
HIM Teknoforge Ltd
HIM Teknoforge Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
A
Apex Ecotech Ltd
Apex Ecotech Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
I
Inflame Appliances Ltd
Inflame Appliances Ltd shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
S
Savera Industries Ltd
Savera Industries Ltd shows potential in a growing sector, but inconsistent growth and execution risks warrant caution.
View details
A
Avro India Ltd
Avro India Ltd presents several risks with inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
E
Equippp Social Impact Technologies Ltd
Equippp Social Impact Technologies Ltd presents several risks with inconsistent growth and profitability metrics. The valuation appears stretched, and governance issues may deter potential investors.
View details
G
Gayatri Projects Ltd
Gayatri Projects Ltd presents several risks, including inconsistent growth and financial health concerns, making it a risky investment at this time.
View details
W
Winsome Textile Industries Ltd
Winsome Textile Industries Ltd shows several weaknesses in growth, profitability, and valuation metrics, making it a risky investment at this time.
View details
M
Mangalam Seeds Ltd
Mangalam Seeds Ltd shows potential in a growing sector, but inconsistent financial performance and governance issues raise concerns.
View details
A
Apollo Finvest (India) Ltd
Apollo Finvest shows potential but faces significant risks and challenges that could hinder growth and profitability.
View details
V
VEGA Jewellers Ltd
VEGA Jewellers Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Coral Laboratories Ltd is a leading player in the Indian pharmaceutical sector, specializing in high-quality healthcare products. Catering primarily to healthcare professionals and patients, the company is committed to enhancing the quality of life through innovative solutions. With a strong focus on research and development, Coral Laboratories ensures that its offerings meet the highest standards of safety and efficacy. This dedication to excellence not only builds trust among consumers but also positions the company for sustainable growth in a competitive market.
- Established leader in the Indian pharmaceutical industry
- Focus on high-quality healthcare solutions
- Innovative research and development initiatives
- Commitment to safety and efficacy
- Strong consumer trust and brand reputation
Investment Thesis
Coral Laboratories Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company is well-positioned to leverage market trends and deliver robust returns.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth runway.
- Attractive valuation metrics compared to industry peers make it a favorable buy.
- Strategic initiatives in place to capitalize on emerging market opportunities.
- Solid financial performance and consistent dividend payouts strengthen investment appeal.
Opportunity vs Risk
Opportunities
- Strong growth in healthcare sector
- Expansion into new markets
- Innovative product pipeline
- Strategic partnerships with hospitals
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in industry
- Dependence on key suppliers
- Economic downturn affecting demand
Peer Perspective
Coral Laboratories Ltd trades at a discount to peers like Alkem Laboratories and Cipla, with a need for margin stability and consistent growth to attract investor interest and justify a potential rerating.
Future Outlook
Coral Laboratories Ltd is well-positioned for growth, leveraging its innovative product pipeline. Successful execution and effective cost control will be crucial in navigating market challenges and maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Coral Laboratories Ltd do?A: Coral Laboratories Ltd specializes in manufacturing and marketing pharmaceutical products and healthcare solutions.
- Q: Is Coral Laboratories Ltd a profitable company?A: Profitability can vary; check recent financial statements for the latest performance details.
- Q: How can I invest in Coral Laboratories Ltd?A: You can invest through a stockbroker or an online trading platform that offers Indian stocks.
- Q: What are the risks of investing in Coral Laboratories Ltd?A: Investing in stocks carries risks, including market volatility and company-specific challenges.
- Q: Where can I find more information about Coral Laboratories Ltd?A: Visit their official website or check financial news platforms for updates and reports.
📊 Stock Investment Checklist (100 Points)
Coral Laboratories Ltd • Updated: 2025-09-17 01:45:40
-
8BusinessHighThe company operates in the pharmaceutical sector, which is generally considered future-ready due to increasing healthcare demands.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate, but cash flow has been volatile compared to net profit.
-
9ValuationHighP/E and P/B ratios are slightly above industry averages, indicating potential overvaluation.
-
7BalanceHighThe company maintains a reasonable debt/equity ratio, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but there are concerns regarding pledging of shares.
-
8DriversHighThere are growth drivers in product expansion, but execution risks remain.
-
4TechnicalsGoodMarket sentiment is neutral with low liquidity and mixed price action.
Final Score & Verdict
Score 54 / 100
• Decent
Coral Laboratories Ltd shows potential in a growing sector, but faces challenges in consistent growth and profitability.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100